HDAC inhibitor-based therapies: can we interpret the code?
Abnormal epigenetic control is a common early event in tumour progression, and aberrant acetylation in particular has been implicated in tumourigenesis. One of the most promising approaches towards drugs that modulate epigenetic processes has been seen in the development of inhibitors of histone dea...
Những tác giả chính: | New, M, Olzscha, H, La Thangue, N |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
2012
|
Những quyển sách tương tự
-
The TLR adaptor protein MyD88 mediates cell sensitivity to HDAC inhibitors through a cytokine-dependent mechanism
Bằng: Sheikh, S, et al.
Được phát hành: (2016) -
A regulatory circuit that involves HR23B and HDAC6 governs the biological response to HDAC inhibitors.
Bằng: New, M, et al.
Được phát hành: (2013) -
A regulatory circuit that involves HR23B and HDAC6 governs the biological response to HDAC inhibitors
Bằng: New, M, et al.
Được phát hành: (2013) -
HDAC inhibitor-based therapies and haematological malignancy.
Bằng: Stimson, L, et al.
Được phát hành: (2009) -
TLR adaptor protein MYD88 mediates sensitivity to HDAC inhibitors via a cytokine-dependent mechanism
Bằng: New, M, et al.
Được phát hành: (2016)